Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XXII | US
0.05
11.52%
Healthcare
Biotechnology
30/06/2024
08/06/2026
0.52
0.48
0.54
0.46
22nd Century Group Inc. an agricultural biotechnology company focuses on tobacco harm reduction reduced nicotine tobacco and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical therapeutic and agricultural uses as well as other applications. 22nd Century Group Inc. was founded in 1998 and is headquartered in Buffalo New York.
View LessLow Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
133.5%1 month
131.7%3 months
119.7%6 months
113.6%-
-
0.38
-10.72
0.43
-0.47
0.39
-
-27.08M
16.22M
16.22M
-
-25.76
-
-1.30
-105.57
0.02
1.04
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.14
Range1M
0.30
Range3M
3.65
Rel. volume
0.50
Price X volume
131.95K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Edesa Biotech Inc | EDSA | Biotechnology | 5.37 | 17.44M | -1.65% | n/a | 1.35% |
| Outlook Therapeutics Inc | OTLK | Biotechnology | 0.722 | 17.08M | -7.04% | n/a | -39.11% |
| Werewolf Therapeutics Inc. Common Stock | HOWL | Biotechnology | 0.3819 | 16.69M | -2.65% | n/a | 35.26% |
| Inhibikase Therapeutics Inc. | IKT | Biotechnology | 1.62 | 16.16M | -0.61% | n/a | 3.49% |
| Aligos Therapeutics Inc | ALGS | Biotechnology | 4.96 | 15.85M | 1.02% | n/a | 14.63% |
| DarT Bioscience Inc | DARE | Biotechnology | 1.85 | 15.81M | -1.60% | 0.12 | 218.34% |
| iBio Inc | IBIO | Biotechnology | 1.73 | 15.81M | -4.95% | n/a | 20.92% |
| Enveric Biosciences Inc | ENVB | Biotechnology | 1.75 | 15.61M | -2.78% | n/a | 0.00% |
| Enlivex Therapeutics Ltd | ENLV | Biotechnology | 0.7142 | 15.29M | 0.59% | n/a | 2.92% |
| NeuroSense Therapeutics Ltd. Ordinary Shares | NRSN | Biotechnology | 0.7516 | 14.89M | 0.20% | n/a | -2.11% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.1 | 16.07M | 7.84% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.4131 | 7.98M | -3.48% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.49 | 3.81M | 12.88% | n/a | 17.32% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0058 | 534.84K | n/a | -37.05% | |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4181 | 230.37K | 7.87% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.47 | 0.53 | Cheaper |
| Ent. to Revenue | 0.39 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.38 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 119.71 | 72.80 | Riskier |
| Debt to Equity | -10.72 | -1.23 | Cheaper |
| Debt to Assets | 0.43 | 0.25 | Expensive |
| Market Cap | 16.22M | 3.66B | Emerging |